human brain News
-
How Tomagatchi Hacked the Human Brain
According to an article from Nerdist, “A team of scientists from the University of Cambridge has used the ‘mini brains’ to analyze serious maladies like lateral sclerosis and even dementia. Something they were able to do thanks to stem cells from patients themselves”. Read the full story here: ...
By ni2o, Inc.
-
Newton Howard at TEDx – The Human Brain
The evolution of humanity is based on the evolution of the human brain. What are the next steps in our evolutionary process and what is the role that technology will play? Dr. Howard leads the Laboratory of Computational Neuroscience in Oxford and the Laboratory of Synthetic Intelligence at MIT. He is a founding member of the Committee of two NGOs: the Howard Brain Sciences Foundation, which ...
By ni2o, Inc.
-
New BESA Research workshop scheduled
The first BESA Research #workshop of 2022 will take place in May, from the 9th through to the 13th, on five consecutive half-days. The time zone will work best for Europe and Asia / Oceania. Basics and advanced methods of M/EEG data analysis in human brain #research will be covered extensively. Briefly, the workshop will include a journey from basic data review and pre-processing through source ...
By BESA GmbH
-
EMOTIV Enlists Two Machine Learning Heavyweights as AI Takes Aim at the Human Brain
EMOTIV, the bioinformatics pioneer advancing understanding of the human brain using electroencephalography (EEG), today added two renowned scientists to its executive leadership team, naming Dr. Gary William Flake as Chief Technology Officer (CTO) and Dr. Scott Rickard as Chief AI Scientist. The new hires underscore EMOTIV’s strategic objectives to meet the quickening pace of advancements ...
By Emotiv Inc.
-
Pesticides linked to childhood brain cancers
There is much grey matter surrounding causes of brain cancer in children, but there is increasing evidence indicating that a culprit may be pre-birth pesticide exposure. In a new study released by the National Institute of Health Sciences, herbicide use appeared to cause an elevated risk for cancer. The study found that children living in homes where their parents use pesticides are twice as ...
-
More than muscles: Sports nutrition evolves
Ingredients for muscle mass and post-workout recovery remain mainstays in sports nutrition, but the category is evolving and broadening. Ingredient examples are phospholipids for cognition and probiotic cultures for digestive health. “It’s very well-known that health is increasingly perceived holistically by consumers, especially younger demographics,” said Paige Wilkinson, ...
By Nuritas Ltd.
-
Synchron Announces First Human U.S. Brain-Computer Interface Implant
Synchron, an endovascular brain-computer interface (BCI) company, today announced the first human BCI implant in the United States. This procedure represents a significant technological milestone for scalable BCI devices and is the first to occur in the U.S. using an endovascular BCI approach, which does not require invasive open-brain surgery. The procedure was performed at Mount Sinai West in ...
-
Artificial Intelligence Fuels Unprecedented Neurosurgical Progress, with Broad Potential Impact
With a deepening focus on unleashing novel applications of artificial intelligence (AI) across—and beyond—neurosurgery, a multidisciplinary team of physicians and mathematicians are collaborating on advanced approaches to diagnosis and patient care, developing data-driven methods that hold potential for progress across the continuum of medicine. A Specialty Uniquely Poised to Lead ...
-
Metlife foundation announces major awards to scientists for research in alzheimer`s disease
The 25th anniversary presentation of the MetLife Foundation Awards for Medical Research in Alzheimer's Disease (AD) was held today honoring two noted researchers, Randy L. Buckner, Ph.D., professor of Psychology and of Neuroscience at Harvard University and Howard Hughes Medical Institute Investigator, and Marcus E. Raichle, M.D., professor of radiology and neurology at Washington University ...
-
This year`s Medical Innovation Summit will highlight neurosciences innovation
Thousands of researchers, investors, entrepreneurs and those who are simply curious will descend upon the Cleveland Convocation Center October 26-28 for Cleveland Clinic Innovations Medical Innovation Summit. This year’s theme, The Neurosciences: Memory. Mood. Movement, will cover all aspects of the human brain and how it functions and malfunctions. “This is our marquee event,” ...
-
BlueRock Therapeutics Announces First Patient Dosed with DA01 in Phase 1 Study in Patients with Advanced Parkinson`s Disease
BlueRock Therapeutics, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, announced today the dose administration for the first patient in a Phase 1 (Ph1), open-label study of pluripotent stem cell-derived dopaminergic neurons in patients with advanced Parkinson’s disease (PD). The purpose of the Ph1 clinical trial is to evaluate the safety, tolerability, ...
-
BrainScope Receives FDA Clearance for Multi-Modal, Multi-Parameter Concussion Assessment
BrainScope®, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, announced today that it has received FDA clearance to include additional language in its product’s Indications for Use (IFU), adding key terminology related to “multi-modal, multi-parameter assessment" of “concussion" and “mild Traumatic Brain ...
-
Berkeley lab awarded $12.8 million in stimulus funds for health research
Lawrence Berkeley National Laboratory has been awarded $12.8 million in American Recovery and Reinvestment Act funding by the National Institutes of Health (NIH) for research into cancer, neurodegenerative diseases, radioactive decontamination and a variety of other health conditions. The grants bring Berkeley Lab’s total Recovery Act funding to more than $240 million in areas covering energy, ...
-
VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to Develop New Drugs for Neurological Disorders
VeriSIM Life (VeriSIM), the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, today announced that it has entered into a partnership agreement with Total Brain, an applied, integrative neuroscience company, to create breakthrough neurodata-driven actionable insights for developing novel drugs to treat a wide range of neurological ...
By VeriSIM Life
-
FONAR Subsidiary, HMCA, Expands with Acquisition in Yonkers, New York
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning, announced today that it has acquired a Stand-Up MRI facility in Yonkers, New York, from where its diagnostic imaging management subsidiary, Health Management Company of America (HMCA) will provide non-medical management services for Comprehensive MRI of New York, P.C. Tim Damadian, president and CEO of FONAR Corporation, said, ...
-
FONAR Set to Join Russell 3000 and 2000 Indexes
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning, reported today that upon the opening of U.S. markets on June 29, 2020, FONAR will, as part of the annual reconstitution of the Russell Indexes, be joining the broad-market Russell 3000 Index and the Russell 2000 Index. The Russell 3000 Index is a market-capitalization-weighted equity index that tracks the performance of the 3,000 ...
-
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
Implied total company value of up to USD 1 billion, inclusive of 40.8 percent stake currently held by Bayer Initial focus in neurology, cardiology, and immunology with start of first clinical program in Parkinson’s disease expected later this year BlueRock Therapeutics to continue to operate as an independent company Bayer AG and BlueRock Therapeutics today announced an agreement ...
-
FONAR Celebrates the 50th Anniversary of the Origination of the MRI
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™, celebrated a special anniversary on September 17, 2019: It was 50 years ago that Raymond V. Damadian, M.D., founder and chairman of FONAR Corporation, first thought about developing a device using magnetic resonance to scan the human body to detect cancer. On September 17, 1969, Dr. Damadian sent a letter to Dr. George Mirick ...
-
Fonar Board of Directors Appoints Independent Director
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning, today announced that on November 17, 2021, its board of directors appointed John Collins as a replacement independent director to a vacancy on the Company´s board of directors and audit committee. Timothy Damadian, president and CEO of FONAR, said, “Our primary source of income and growth is attributable to FONAR’s ...
-
Bayer raises peak sales for Nubeqa to exceed three billion euro amid positive Phase III ARASENS trial data
Raise in peak sales expectations follows presentation of positive Phase III trial ARASENS with darolutamide (Nubeqa) in metastatic hormone-sensitive prostate cancer at 2022 ASCO GU Cancers Symposium and publication in The New England Journal of Medicine on February 17, 2022 Broad development program underway with three additional ongoing or planned large clinical studies for darolutamide ...
By Bayer AG
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you